Literature DB >> 7631749

Utilization and preferred metabolic pathway of ketone bodies for lipid synthesis by isolated rat hepatoma cells.

L A Hildebrandt1, T Spennetta, C Elson, E Shrago.   

Abstract

Morris hepatoma 7777 cells freshly isolated from highly malignant tumors grown in the hindlimb of buffalo rats actively convert ketone bodies to cholesterol and fatty acids. On the basis of results obtained with (-)-hydroxycitrate, an inhibitor of the ATP citrate lyase enzyme, the metabolic pathway for acetoacetate conversion to lipids is exclusively cytoplasmic, whereas that for 3-hydroxybutyrate involves both extra- and intramitochondrial compartments. Subcellular distribution studies indicated accumulation and compartmentation of 3-hydroxybutyryl CoA primarily in the cytoplasm of hepatoma cells incubated with either ketone body. In contrast, the compartmentation of acetoacetyl CoA is dependent on whether the substrate is acetoacetate or 3-hydroxybutyrate. With acetoacetate, the acetoacetyl CoA is entirely cytoplasmic, whereas with 3-hydroxybutyrate, it is equally divided between the intra- and extramitochondrial compartments. The results are discussed in terms of the known and proposed metabolic pathways for lipid synthesis from ketone bodies, particularly that from 3-hydroxybutyrate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631749     DOI: 10.1152/ajpcell.1995.269.1.C22

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  The vital role of ATP citrate lyase in chronic diseases.

Authors:  Amrita Devi Khwairakpam; Kishore Banik; Sosmitha Girisa; Bano Shabnam; Mehdi Shakibaei; Lu Fan; Frank Arfuso; Javadi Monisha; Hong Wang; Xinliang Mao; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  J Mol Med (Berl)       Date:  2019-12-19       Impact factor: 4.599

2.  Abnormalities in Plasma Phospholipid Fatty Acid Profiles of Patients with Hepatocellular Carcinoma.

Authors:  Jian-Feng Qiu; Ke-Lin Zhang; Xiao-Jing Zhang; Yuan-Jia Hu; Peng Li; Chang-Zhen Shang; Jian-Bo Wan
Journal:  Lipids       Date:  2015-08-21       Impact factor: 1.880

3.  Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV.

Authors:  H Akkiz; B I Carr; V Guerra; R Donghia; K Yalçın; U Karaoğullarından; E Altıntaş; A Özakyol; H Şimşek; H Y Balaban; A Balkan; A Uyanıkoğlu; N Ekin; A Delik
Journal:  J Transl Sci       Date:  2020-09-16

Review 4.  Lipids changes in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Xiao-Ying Zhang; Chang-Ping Wu
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

5.  Identification and characterization of an extramitochondrial human 3-hydroxy-3-methylglutaryl-CoA lyase.

Authors:  Christa Montgomery; Zhengtong Pei; Paul A Watkins; Henry M Miziorko
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

6.  Fenofibrate Induces Ketone Body Production in Melanoma and Glioblastoma Cells.

Authors:  Maja M Grabacka; Anna Wilk; Anna Antonczyk; Paula Banks; Emilia Walczyk-Tytko; Matthew Dean; Malgorzata Pierzchalska; Krzysztof Reiss
Journal:  Front Endocrinol (Lausanne)       Date:  2016-02-02       Impact factor: 5.555

Review 7.  Regulation of Ketone Body Metabolism and the Role of PPARα.

Authors:  Maja Grabacka; Malgorzata Pierzchalska; Matthew Dean; Krzysztof Reiss
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

8.  Potential Role of HMGCS2 in Tumor Angiogenesis in Colorectal Cancer and Its Potential Use as a Diagnostic Marker.

Authors:  Kejian Zou; Yan Hu; Musheng Li; Hongli Wang; Yuhua Zhang; Ling Huang; Yuanwen Xie; Songyu Li; Xingui Dai; Wanfu Xu; Zhiyong Ke; Sitang Gong; Yaodong Wang
Journal:  Can J Gastroenterol Hepatol       Date:  2019-07-01

Review 9.  A high-protein diet for reducing body fat: mechanisms and possible caveats.

Authors:  Dominik H Pesta; Varman T Samuel
Journal:  Nutr Metab (Lond)       Date:  2014-11-19       Impact factor: 4.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.